House of Lords Business
Show full summary

Lord Hunt of Kings Heath to ask Her Majesty's Government what steps they are taking to ensure medicines licensed by the Medicines and Healthcare products Regulatory Agency (MHRA), through Oribis and the Innovative Licensing and Access Pathway (ILAP), are promptly reimbursed by the NHS.  HL753

Question HL753: tabled on 7 June 2021 and due for answer by 21 June 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Hunt of Kings Heath to ask Her Majesty's Government what steps they are taking to ensure medicines licensed by the Medicines and Healthcare products Regulatory Agency (MHRA), through Oribis and the Innovative Licensing and Access Pathway (ILAP), are promptly reimbursed by the NHS.  HL753
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Hunt of Kings Heath
Labour
Life peer